<DOC>
	<DOCNO>NCT01471990</DOCNO>
	<brief_summary>The purpose study examine compare effect pituitary adenylate cyclase-activating polypeptide-38 ( PACAP38 ) vasoactive intestinal polypeptide ( VIP ) intracranial artery neuronal activity patient migraine without aura use high resolution magnetic resonance imaging ( MRI ) , include MR angiography ( MRA ) functional MRI ( fMRI ) . MRA use detect change intracranial artery circumference PACAP38 VIP . fMRI use oo detect change blood-oxygenation-level-dependent-signal ( BOLD-signal ) . PACAP38 VIP induce migraine like attack migraine patient . The migraine specific drug sumatriptan give relieve pain effect also register use MRA fMRI .</brief_summary>
	<brief_title>Effect PACAP38/VIP Migraineurs Measured Magnetic Resonance</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine without Aura</mesh_term>
	<mesh_term>Pituitary Adenylate Cyclase-Activating Polypeptide</mesh_term>
	<mesh_term>Vasoactive Intestinal Peptide</mesh_term>
	<criteria>Healthy migraine patient without aura Age 1840 Weight 50100 kg Fertile woman must use safe contraceptive Tension type headache 5 day per month Other primary headache Daily use medication except contraceptive Drug take within 4 time half life specific drug except contraceptive Pregnant lactate woman Exposure radiation within last year Hypotension hypertension Cardiovascular cerebrovascular disease Mental illness substance abuse Other significant condition determine examine doctor Contraindications MRI scan Headache within last 48 hour start trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>PACAP38</keyword>
	<keyword>MMA</keyword>
	<keyword>migraine</keyword>
	<keyword>angiography</keyword>
	<keyword>VIP</keyword>
	<keyword>vasodilatation</keyword>
</DOC>